Aprea Therapeutics's total assets for Q1 2026 were $48.11M, an increase of 201.96% from the previous quarter. APRE total liabilities were $5.30M for the fiscal quarter, a 51.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.